5AM Partners VI, LLC bought $4.5M of CAMP4 THERAPEUTICS (CAMP)
Executed Sep 11 2025, disclosed Sep 16 2025, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Sep 15 2025), the stock returned +14.6% (delay-adjusted); from the execution session (Sep 11 2025), +44.7%. Derived: entry at the session's open, exit at the close 20 sessions later.
5AM Partners VI, LLC (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). Across 1 priced purchase filing, the average 21-session return was +44.7% from execution and +14.6% from disclosure (delay-adjusted; derived). The largest single filing was $4.5M of CAMP (2,941,176 sh × $1.53, as filed), executed Sep 11 2025.
Healthcare · Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→